medigraphic.com
ISSN 0185-6014 (Print)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2003, Number 2

<< Back Next >>

Rev Mex Patol Clin Med Lab 2003; 50 (2)

Genitourinary diseases and mycoplasmas

José Antonio Sánchez Hernández, José Antonio Rivera Tapia, Socorro Aradid Cortés Martínez, Nataly Tlecuitl Mendoza, Fabiola Méndez Valderrábano

Language: Spanish
References: 18
Page: 71-76
PDF size: 56.17 Kb.


ABSTRACT

Complications of infection by mycoplasmas include disorders hematopoietic, cardiovascular, central nervous, musculoskeletal and gastrointestinal systems. The roles of the genital mycoplasmas Mycoplasma hominis and Ureaplasma urealyticum are controversial but may include infections of the genitourinary tract and in pregnancy as well as diseases of the newborn, such as neonatal pneumonia and meningitis. Ureaplasma urealyticum, a common commensal of the urogenital tract of sexually mature humans, is gaining recognition as an important opportunistic pathogen during pregnancy. Mycoplasma hominis was susceptible to linezolid and evermicin. It was resistant to macrolides and telithromycin. Ureaplasma urealyticum was susceptible to evermicin and resistant to linezolid.


REFERENCES

  1. Bebear C, Dupon M, Renaudin H, de Barbeyrac B. Potential improvements in therapeutic options for mycoplasmal respiratory infections. Clin Infect Dis 1993; 17 (suppl I): 202-207.

  2. Mernaugh GR, Dallo SF, Holt SC, Baseman JB. Properties of adhering and noradhering populations of Mycoplasma genitalium. Clin Infect Dis 1993; 17 (suppl I): 69-78.

  3. De Barbeyrac B, Bernet P et al. Detection of Mycoplasma pneumoniae and Mycoplasma genitalium in clinical samples by polimerase chain reaction. Clin Infect Dis 1993; 17 (suppl I): 83-89.

  4. Eschenbach DA. Ureaplasma urealyticum and premature birth. Clin Infect Dis 1993; 17 (suppl I): 100-106.

  5. Rodvold KA, Pisatelli SC. New oral macrolide and fluoroquinolone antibiotics: An overview of pharmacokinetics, interactions and safety. Clin Infect Dis 1993; 17 (suppl I):192-199.

  6. Taylor RD, Gilory CB, Hay PE. Ocurrence of Mycoplasma genitalium in different populations and its clinical significance. Clin Infect Dis 1993; 17 (suppl I): 66-68.

  7. Miller KE, Graves. Update on the prevention and treatment of sexually transmitted diseases. Am Fam Physician 2000; 61: 379-386.

  8. Bremnor J, Sadousky R. Evaluation of dysuria in adults. Am Fam Physician 2002; 65: 1589-1596.

  9. Tully JG. Current status of the Mollicute flora of humans. Clin Infect Dis 1993; 17 (suppl I): 2-9.

  10. Totten PA, Schwartz MA, Sjöström KE, Kenny GE, Handsfield HH, Weiss JB, Whittington WLH. Association of Mycoplasma genitalium with nongonococcal urethritis in heterosexual men. J Infect Dis 2001; 183: 269-276.

  11. Blanchard A, Hamrick W, Duffy L, Baldus K, Cassell GH. Use of the polymerase chain reaction for detection of Mycoplasma fermentans and Mycoplasma genitalium in the urogenital tract and amniotic fluid. Clin Infect Dis 1993; 17 (suppl I): 272-279.

  12. Blanchard A, Hentschel J, Duffy L, Baldus K, Cassell GH. Detection of Ureaplasma urealyticum by polymerase chain reaction in the urogenital tract of adults, in amniotic fluid, and in the respiratory tract of newborns. Clin Infect Dis 1993; 17 (suppl I): 148-153.

  13. Waites KB, Crouse DT, Cassell GH. Systemic neonatal infection due to Ureaplasma urealyticum. Clin Infect Dis 1993; 17 (suppl I): 131-135.

  14. Hyun YBO, Romero R, Kim M, Kim Tiu-Chong, Kim T et al. Clinical implications of detection of Ureaplasma urealyticum in the amniotic cavity with the polymerase chain reaction. Am J Obstet Gynecol 2000; 183: 1130-1137.

  15. Kenny GE, Cartwright FD. Effect of pH, inoculum size, and incubation time on the susceptibility of Ureaplasma urealyticum to erithromycin in vitro. Clin Infect Dis 1993; 17 (suppl I): 215-218.

  16. Waites KB, Crouse DT, Cassell GH. Therapeutic considerations for Ureaplasma urealyticum infections in neonates. Clin Infect Dis 1993; 17 (suppl I): 208-214.

  17. Mc. Conmack WM. Susceptibility of mycoplasma to antimicrobial agents: Clinical Implications. Clin Infect Dis 1993; 17 (suppl I): 200-201.

  18. Kenny GE, Cartwright FD. Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromicin, evermicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines and quinolones. Antimicrob Agents Chemother 2001; 45: 2604-2608.




2020     |     www.medigraphic.com